AstraZeneca Brilinta Met Primary Endpoint in Phase Three Stroke Trial

AstraZeneca PLC (AZN.LN) said Monday that its drug Brilinta met the primary endpoint in a phase three trial for stroke prevention.
The British pharmaceutical major said high-level results from the phase three THALES trial showed Brilinta used twice daily with aspirin reached a statistically significant reduction in the risk of the primary composite endpoint of stroke and death.
“Results of the Phase three THALES trial showed Brilinta, in combination with aspirin, improved outcomes in patients who had experienced a minor acute ischaemic stroke or high-risk transient ischaemic attack,” Executive Vice President of BioPharmaceuticals R&D Mene Pangalos said.

https://www.marketscreener.com/ASTRAZENECA-4000930/news/AstraZeneca-Brilinta-Met-Primary-Endpoint-in-Phase-Three-Stroke-Trial-29894260/

AstraZeneca Enhertu Phase 2 Trial Meets Primary Endpoint

AstraZeneca PLC (AZN.LN) said on Monday that the Phase 2 trial for Enhertu, its gastric cancer drug, met its primary endpoint.
The U.K. pharmaceutical company said the trial met the primary endpoint of objective response rate and key secondary endpoint of overall survival in patients with previously treated HER2-positive metastatic gastric cancer compared to an investigator’s choice of chemotherapy.
“Given the previous results seen in our HER2-positive development program and now in HER2-positive metastatic gastric cancer, we believe this antibody drug conjugate has the potential to redefine the treatment of patients with HER2-expressing cancers,” the company said.

https://www.marketscreener.com/ASTRAZENECA-4000930/news/AstraZeneca-Enhertu-Phase-2-Trial-Meets-Primary-Endpoint-29894270/

Nestle scoops up Allergan’s Zenpep

Looking to expand in medical nutrition, Nestle (OTCPK:NSRGY) is buying Allergan’s (NYSE:AGN) Zenpep, which had sales of $237M in 2018.

The product caters to people who cannot digest food properly because their pancreas does not provide enough enzymes to break down fat, protein, and carbohydrates.

“This is a significant opportunity for our business in the United States to add a complementary product to our existing range of nutrition products,” said Nestle’s Greg Behar.

https://seekingalpha.com/news/3534546-nestle-scoops-up-allergans-zenpep

Coronavirus outbreak will hit Singapore economy this year: trade minister

Singapore’s economy will be impacted by the outbreak of a new coronavirus that originated in China at the end of last year and has spread to the city-state, its trade minister said on Monday.
The Southeast Asian travel and tourism hub, which recorded its lowest growth rate in a decade last year at 0.7%, has reported four cases of the coronavirus that has killed 80 people in China so far.

“There will certainly be an impact on our economy, business and consumer confidence this year especially as the situation is expected to persist for sometime,” Chan Chun Sing said.
Tourism-related sectors were of immediate concern and the government was ready to support firms and workers, he said.
Chinese nationals make up the largest share of visitors to Singapore, one of the worst hit countries outside of China in the 2003 outbreak of Severe Acute Respiratory Syndrome (SARS).
https://www.reuters.com/article/us-china-health-singapore/coronavirus-outbreak-will-hit-singapores-economy-this-year-trade-minister-idUSKBN1ZQ095?il=0

Alibaba’s Taobao takes down overpriced face masks on its marketplace

Alibaba’s Taobao marketplace said on Sunday that it has removed sales of face masks from shops that show “unstable prices or false advertising”, as prices for the products surged as Chinese consumers race to protect themselves from the coronavirus outbreak.

The newly identified coronavirus has created alarm because much about it is still unknown, such as how dangerous it is and how easily it spreads between people. It can cause pneumonia, which has been deadly in some cases.

https://www.marketscreener.com/news/Alibaba-s-Taobao-takes-down-overpriced-face-masks-on-its-marketplace–29893831/

U.S. stock futures fall more than 1% as coronavirus fears spread

U.S. S&P500 e-mini futures fell more than 1% in Asian trade on Monday on mounting worries the new coronavirus outbreak could severely disrupt the Chinese economy, an engine of global growth.

China’s cabinet said it would extend the week-long Lunar New Year holiday by three days to Feb. 2 and Hong Kong banned residents of China’s Hubei province, where the new coronavirus outbreak was first reported, from entering the city.

https://www.marketscreener.com/news/U-S-stock-futures-fall-more-than-1-percent-as-coronavirus-fears-spread–29893878/

PerkinElmer Q4 2019 Earnings Preview

PerkinElmer (NYSE:PKI) is scheduled to announce Q4 earnings results on Monday, January 27th, after market close.

The consensus EPS Estimate is $1.33 (+12.7% Y/Y) and the consensus Revenue Estimate is $801.14M (+5.9% Y/Y).

Over the last 2 years, PKI has beaten EPS estimates 75% of the time and has beaten revenue estimates 63% of the time.

Over the last 3 months, EPS estimates have seen 0 upward revisions and 8 downward. Revenue estimates have seen 0 upward revisions and 8 downward.

https://seekingalpha.com/news/3534539-perkinelmer-q4-2019-earnings-preview